The study evaluated its impact on breast cancer proliferation, cell cycle arrest, and apoptosis and found no statistically significant differences in Ki-67, a marker of cell-proliferation, pre- or post- treatment, which was the primary endpoint of our study. Here, MKI67 is linked to breast carcinoma.